PEOPLE - Molecular Biosystems makes appointment:
This article was originally published in Clinica
Executive Summary
Molecular Biosystems, a US developer of ultrasound imaging agents, has appointed Thomas Jurgensen vice-president of legal affairs and general counsel, and Robert Giargiari director of investor relations. In addition, Stephen Keane will take the role of director of business development. Mr Jurgensen was most recently with Ligand Pharmaceuticals and Mr Giargiari with Sequana Therapeutics.